Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues

NCT02427295 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Acromegaly

Interventions

DRUG: Sandostatin (Octreotide Acetate)

Sponsor

Asan Medical Center

Collaborators

[object Object]